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Bacteria colonizing the human intestine have a relevant role in the spread of antimicrobial
resistance. We investigated the faecal carriage of extended-spectrum beta-lactamase
(ESBL)-producing Enterobacteriaceae in healthy humans from Portugal and analyzed the
distribution of sul genes and class 1 and 2 integrons. Faecal samples (n = 113) were
recovered from healthy persons (North/Centre of Portugal, 2001–2004) and plated on
MacConkey agar with and without ceftazidime (1mg/L) or cefotaxime (1mg/L). Isolates
representing different morphotypes/plate and antibiotic susceptibility patterns (n = 201)
were selected. Isolates resistant to sulfonamides and/or streptomycin, gentamicin, and
trimethoprim were screened (PCR and sequencing) for sul genes (sul1, sul2, sul3)
and class 1 and 2 integrons. Presence of ESBLs was inferred using the double disk
synergy test (DDST) and further confirmed by PCR and sequencing. ESBL producers were
selected for clonal analysis, plasmid characterization and conjugation assays by standard
methods. ESBL-producing isolates were found in 1.8% (2/113) of samples, corresponding
to Escherichia coli of phylogroups A (n = 1) and B1 (n = 1) carrying transferable blaCTX-M-14
and the new blaTEM-153, respectively. A 80kb IncK plasmid bearing blaCTX-M-14 was found,
being highly related to that widely spread among CTX-M-14 producers of humans and
animals from Portugal and other European countries. sul genes were found in 88% (22/25;
sul2-60%, sul1-48%, sul3-4%) of the sulfonamide resistant isolates. Class 1 integrons
were more frequently found than class 2 (7%, 14/201 vs. 3%, 6/201). Interestingly,
gene cassette arrangements within these platforms were identical to those commonly
observed among Enterobacteriaceae from Portuguese food-producing animals, although
aadA13 is here firstly described in Morganella morganii. These results reinforce the
relevance of human commensal flora as reservoir of clinically relevant antibiotic resistance
genes including blaESBLs, and highly transferable genetic platforms as IncK epidemic
plasmids.
Keywords: ESBLs, CTX-M-14, TEM-153, class 1 and class 2 integrons, healthy volunteers
INTRODUCTION
Antimicrobial resistance has become a global public health
problem, compromising the treatment of several infectious dis-
eases. Acquisition of integrons and beta-lactamase genes by
Enterobacteriaceae is increasingly recognized, being associated
with resistance to multiple antibiotics (Machado et al., 2007;
Coque et al., 2008; Bush, 2010; Pitout, 2010). The production
of extended-spectrum beta-lactamases (ESBLs) constitutes one of
the currently most spread and relevant antibiotic resistancemech-
anisms, compromising the use of several beta-lactams. Portugal is
one of the European countries with higher rates of ESBL produc-
ers in the clinical setting, with a shift from TEM or SHV variants
to CTX-M-types noticed since 2003 (Machado et al., 2007; ECDC,
2011).
Colonization of healthy subjects with antibiotic resistant
Enterobacteriaceae could contribute to the amplification of resis-
tant bacteria both at community and nosocomial settings
(Rodríguez-Baño et al., 2008; Valverde et al., 2008). High rates
of antibiotic resistant Escherichia coli fecal isolates of healthy
humans have been reported in different countries (London et al.,
1994; van de Mortel et al., 1998; Zhang et al., 1998; Sáenz
et al., 2001; Briñas et al., 2002; Bruinsma et al., 2003; Nys et al.,
2004; Bailey et al., 2010). In Portugal, spread of multidrug resis-
tant bacteria, including ESBL producers, in hospitals, healthy
food-producing animals, food products and aquatic settings has
been described (Machado et al., 2007, 2008, 2009; Mendonça
et al., 2007). Nevertheless, their occurrence and diversity in
healthy populations is unknown. In order to better understand
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the epidemiology of multidrug resistant Enterobacteriaceae in
Portugal and the contribution of different settings to the burden
of infections with antibiotic resistant bacteria, we investigated,
during the initial spread period of CTX-M enzymes, the faecal
carriage of ESBL-producing Enterobacteriaceae, class 1 and class 2
integrons, and sul genes in Portuguese healthy humans.
MATERIALS AND METHODS
BACTERIAL ISOLATES
From January 2001 to February 2004, a total of 113 nonduplicate
faecal samples were recovered from randomly selected healthy
humans [53% females; age ranging from 5 to 59 (n = 99) and
60 to 76 (n = 14) years old] living in the North and Centre of
Portugal. Samples were from persons without previous expo-
sure to antibiotic therapy, hospitals, or long-term care facilities
at least in the 3-month period before sampling. Rectal swabs
were immersed in transport medium, faeces suspended in 1mL
of saline, and aliquots of 200μL seeded in MacConkey agar
with and without ceftazidime (1mg/L) or cefotaxime (1mg/L).
Presumptive Enterobacteriaceae (oxidase-negative facultative aer-
obic Gram negative rods) were selected for further studies.
Enterobacteriaceae isolates recovered in the same time period
from Portuguese hospitals (n = 4; 2003–2004) or marine coastal
waters (n = 1; 2003) close to clandestine discharge points of
water streams contaminated with faecal coliforms, and producing
ESBL-types similar to the ones identified in this study, were also
included for clonal investigation and/or plasmid relationships
analysis (Machado et al., 2007, 2009).
ESBL DETECTION AND ANTIMICROBIAL SUSCEPTIBILITY
Each different morphotype growing onMacConkey agar with cef-
tazidime or cefotaxime was screened for ESBL production by the
double disk synergy test (DDST) (Jarlier et al., 1988), and suscep-
tibility testing to non-beta-lactam antibiotics (aminoglycosides,
quinolones, sulfonamides, trimethoprim, tetracyclines, chloram-
phenicol) was carried out in positive isolates using the standard
disk diffusion method (CLSI, 2007). Morphotypes correspond-
ing to non-ESBL producers recovered fromMacConkey agar with
and without antibiotics were tested to streptomycin, gentamicin,
trimethoprim and sulfonamides (CLSI, 2007).
ESBL CHARACTERIZATION AND EPIDEMIOLOGICAL FEATURES
Characterization of ESBLs was performed by amplification of
bla genes and sequencing (Table 1), and ESBL-producing iso-
lates were further identified by API ID 32GN (bioMérieux, Marcy
l’Étoile, France). Clonal relatedness of ESBL producers was inves-
tigated by pulsed-field gel electrophoresis (PFGE), randomly
amplified polymorphic DNA (RAPD) (Machado et al., 2005,
2008), and multilocus sequence typing (MLST) (http://mlst.ucc.
ie/mlst/dbs/Ecoli). E. coli phylogenetic groups were identified by
a multiplex PCR (Clermont et al., 2000).
The transferability of ESBL genes was assessed by filter mating
assays with E. coli BM21R (nalidixic acid- and rifampicin resis-
tant, lactose fermentation positive and plasmid-free) (Machado
et al., 2008), and ESBL-encoding plasmids were identified by
PCR-based replicon typing and further hybridization (blaESBL,
rep probes), as previously described (Novais et al., 2010). Plasmid
relationships were established by comparison of restriction frag-
ment length polymorphism (RFLP) patterns obtained after diges-
tion with EcoRI, PstI, and HpaI restriction enzymes (Valverde
et al., 2009).
CHARACTERIZATION OF INTEGRONS AND sul GENES
Isolates representing different morphotypes and resistance pat-
terns to streptomycin, gentamicin, trimethoprim and/or sulfon-
amides were selected for screening of class 1 and class 2 integrons
by PCR (Table 1), as these phenotypes are commonly associ-
ated with these genetic structures (Machado et al., 2005). Class 1
and class 2 integrons were further characterized by RFLP-typing
and sequencing, as described (Machado et al., 2005). Integrons
were designated by roman numbers and a subindex indicates
the class to which each integron belongs, as previously described
(Machado et al., 2005). Isolates resistant to sulfonamides were
also screened for the presence of sulfonamide resistance genes
(sul1, sul2, sul3) by PCR (Table 1).
RESULTS
EPIDEMIOLOGICAL BACKGROUND
A total of 201 Enterobacteriaceae isolates representing differ-
ent colony morphotypes and antibiotic susceptibility patterns
were obtained. Resistance to at least one antibiotic was observed
in 79 isolates, and the resistance rates were higher for strep-
tomycin (36%, 73/201) than for trimethoprim (15%, 31/201),
sulfonamides (12%, 25/201), or gentamicin (4%, 9/201).
The proportion of faecal carriage of ESBL-producing
Enterobacteriaceae was 1.8% (2 of 113 samples), corresponding
to samples recovered in 2003 from two females, aged 21 and 76
years, respectively.
ESBL CHARACTERIZATION
We identified Escherichia coli isolates producing CTX-M-14
(phylogroup A, ST665) or TEM-153 (phylogroup B1), a novel
TEM-type enzyme differing from TEM-1 by three amino acid
changes (E104K, M182T, and G267V) (GenBank accession num-
ber KC149518). TEM-1 enzyme was also identified in the CTX-
M-14 producer. The CTX-M-14-producing E. coli isolate showed
a phenotype of resistance against streptomycin, sulfonamides,
trimethoprim, tetracyclines, chloramphenicol, nalidixic acid, and
ciprofloxacin, while the TEM-153 producer was only resistant to
nalidixic acid, ciprofloxacin, and neomycin.
Both ESBLs were successfully transferred by conjugation,
and resistance to streptomycin was co-transferred with the
blaCTX-M-14 gene. A clonal relationship was not established
between CTX-M-14-producing E. coli recovered from healthy
volunteers and from Portuguese hospitalized patients or marine
coastal waters (Machado et al., 2007, 2009). However, the plasmid
containing blaCTX-M-14, a 80kb IncK-blaCTX-M-14 plasmid, was
similar to that of hospitalized patients from Portugal and other
European countries (Valverde et al., 2009; Cottell et al., 2011; data
not shown).
ANALYSIS OF INTEGRONS
Class 1 and/or class 2 integrons were detected in 9% (19/201) of
the isolates, being class 1 integrons more frequently found than
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Table 1 | Primers used in this study.
Primer Oligonucleotide sequence (5′–3′) Gene Reference
TEM-F ATG AGT ATT CAA CAT TTC CG blaTEM Rasheed et al., 1997
TEM-R CTG ACA GTT ACC AAT GCT TA
SHV-1 GGG TTA TTC TTA TTT GTC GC blaSHV Rasheed et al., 1997
SHV-2 TTA GCG TTG CCA GTG CTC
CTX-M-F′ TTT GCG ATG TGC AGT ACC AGT AA blaCTX-M Edelstein et al., 2003
CTX-M-R′ CGA TAT CGT TGG TGG TGC CAT A
CTXM1-F3 GAC GAT GTC ACT GGC TGA GC blaCTX-M (group I) Pitout et al., 2004
CTXM1-R2 AGC CGC CGA CGC TAA TAC A
Toho1-F2 GCG ACC TGG TTA ACT ACA ATC C blaCTX-M (group II) Pitout et al., 2004
Toho1-1R CGG TAG TAT TGC CCT TAA GCC
CTXM825F CGC TTT GCC ATG TGC AGC ACC blaCTX-M (group III) Pitout et al., 2004
CTXM825R GCT CAG TAC GAT CGA GCC
CTXM924F GCT GGA GAA AAG CAG CGG AG blaCTX-M (group IV) Pitout et al., 2004
CTXM924R GTA AGC TGA CGC AAC GTC TG
CTX-M-9-F GTG ACA AAG AGA GTG CAA CGG blaCTX-M (group IV, sequencing) Simarro et al., 2000
CTX-M-9-D ATG ATT CTC GCC GCT GAA GCC
IntI1-F GGT CAA GGA TCT GGA TTT CG intI1 Mazel et al., 2000
IntI1-R ACA TGC GTG TAA ATC ATC GTC
5′CS GGC ATC CAA GCA GCA AG Class 1 integron variable region Levesque et al., 1995
3′CS AAG CAG ACT TGA CCT GA
IntI2-F CAC GGA TAT GCG ACA AAA AGG T intI2 Mazel et al., 2000
IntI2-R GTA GCA AAC GAG TGA CGA AAT G
attI2-F GAC GGC ATG CAC GAT TTG TA Class 2 integron variable region Machado et al., 2005
orfX-R GAT GCC ATC GCA AGT ACG AG
Sul 1-F CGGCGTGGGCTACCTGAACG sul1 Kerrn et al., 2002
Sul 1-B GCCGATCGCGTGAAGTTCCG
Sul 2-F GCGCTCAAGGCAGATGGCATT sul2 Kerrn et al., 2002
Sul 2-B GCGTTTGATACCGGCACCCGT
sul3F GAGCAAGATTTTTGGAATCG sul3 Perreten and Boerlin, 2003
sul3R CATCTGCAGCTAACCTAGGGCTTTGGA
Table 2 | Class 1 and class 2 integron types found among Enterobacteriaceae recovered from faecal samples of Portuguese healthy humans.
RFLP type Length of variable region (bp) Gene cassettes and order Resistance phenotypea No. of isolates Isolation date
CLASS 1 INTEGRONS
I1 1000 aadA1 Sm, Sp 2 2001
II1 1500 dfrA1-aadA1 Tp, Sm, Sp 3*b 2003/2004
III1 1800 dfrA12-orfF-aadA2 Tp, Sm, Sp 1 2001
VI1 1500 dfrA17-aadA5 Tp, Sm, Sp 3 2001/2003
XXIV1 1400 aadA13 Sm, Sp 3 2001
CLASS 2 INTEGRONS
II2 1900 dfrA1-sat2-aadA1-orfX Tp, Str, Sm, Sp 4 2001/2004
III2 2300 estX-sat2-aadA1-orfX Str, Sm, Sp 1 2004
aSm, streptomycin; Sp, spectinomycin; Str, streptothricin; Tp, trimethoprim.
b(*) One isolate corresponded to the CTX-M-14-producing E. coli.
class 2 integrons [7% (14/201) vs. 3% (6/201)]. Simultaneous
presence of class 1 and class 2 integrons was found in one iso-
late. A low diversity of integrons and of their gene cassettes was
observed (Table 2). Five different class 1 integron types were iden-
tified, with types II1 (dfrA1-aadA1, n = 3), VI1 (dfrA17-aadA5,
n = 3) and XXIV1 (aadA13, n = 3) corresponding to the most
prevalent. Among ESBL-producing isolates, class 1 integrons were
only identified in the CTX-M-14 producer, with the integron
(type II1, dfrA1-aadA1) and the blaESBL gene being co-transferred
by conjugation. Two class 2 integron types were observed: type II2
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(dfrA1-sat2-aadA1-orfX) (n = 4) and type III2 (estX-sat2-aadA1-
orfX) (n = 1). Gene cassettes were not identified in few isolates
harboring intI1 (2/201, 1%) or intI2 (1/201, 0.5%).
DISTRIBUTION OF sul GENES
The sul genes were found among 88% (22/25) of the sulfon-
amide resistant isolates, corresponding to sul1 (48%, 12/25),
sul2 (60%, 15/25), and sul3 (4%, 1/25), with simultaneous pres-
ence of sul1 and sul2 in 24% (6/25) of the isolates. A high
proportion of sul genes was detected among isolates harbor-
ing class 1 integrons [64%, 14/22; sul1-92% (11/12); sul2-47%
(7/15); sul3-100% (1/1)], corresponding to a prevalence of sul
genes in integron-positive isolates of 100% (14/14). In one iso-
late harboring intI1 but negative for sul1 we detected the presence
of sul3.
DISCUSSION
The rate of faecal carriage of ESBL-producing Enterobacteriaceae
found in Portuguese healthy persons was similar to that reported
in Spain and other countries during the same time period
(Valverde et al., 2004; Moubareck et al., 2005; Rodrigues et al.,
2005). In Portugal, available data on faecal carriage of ESBL-
producing Enterobacteriaceae by healthy humans is scarce and
restricted to children (Guimarães et al., 2009). However, several
works demonstrate a wide dissemination of ESBLs in Portuguese
clinical settings, healthy food-producing animals, food prod-
ucts and aquatic environments since 2003, accompanied by
a shift in the ESBL-types from TEM- or SHV-types towards
CTX-M enzymes (Machado et al., 2004, 2007, 2008, 2009;
Mendonça et al., 2007; Peixe and Machado, personal communi-
cation). In face of this scenario, the presence of ESBL-producing
Enterobacteriaceae in the commensal intestinal flora of Portuguese
healthy humans was not surprising, being even predictable that
future studies will report an increase in the faecal carriage of
ESBL producers, as demonstrated in other works (Valverde et al.,
2004; Pallecchi et al., 2007; Vinué et al., 2009; Woerther et al.,
2010).
The ESBL-producing E. coli clones identified belonged to A
or B1 phylogenetic groups. These phylogroups have tradition-
ally been considered “commensal” (Johnson and Stell, 2000),
although they have been increasingly recovered from human
infections, very often from blood cultures (Moreno et al.,
2006; Cooke et al., 2010; Rodríguez-Baño et al., 2012; Novais
and Peixe, unpublished data). The detection of CTX-M-14-
producing E. coli isolates from hospitalized patients and marine
coastal waters clonally unrelated (phylogroup D) to the one
from a Portuguese healthy person in the same time period,
but sharing an identical IncK plasmid carrying blaCTX-M-14
also identified in Spain and other countries (Coque et al.,
2008; Valverde et al., 2009; Cottell et al., 2011), highlights the
role of transferable plasmids in the global and local spread
of antibiotic resistance among different reservoirs. The TEM-
153 reported by the first time in this study seems to evolve
from blaTEM-1c (Leflon-Guibout et al., 2000), a blaTEM-1 variant
identified among animals and predominant among faecal iso-
lates from healthy humans (Briñas et al., 2002). This enzyme is
highly similar to TEM-52 (99% homology at aminoacid level,
G238S, and V267G), an ESBL-type widely spread in piggeries,
chicken meat, and hospitals in Portugal and Europe (Coque
et al., 2008; Machado et al., 2008; Peixe and Machado, personal
communication).
Although limitations derived from the low number of ESBL-
producing isolates included in our study, these data suggest
that bacteria colonizing healthy persons constitute a reservoir
of new or known ESBL genes that could further evolve at the
nosocomial setting and/or be responsible for future epidemic
situations. Despite the initial reports of CTX-M-15 producers in
several Portuguese hospitals in 2003–2004 (Machado et al., 2007)
and the recent studies indicating a high prevalence of CTX-M-
15 among the faecal flora of healthy individuals (reflecting its
current dominance in the ESBL pandemic) (Moubareck et al.,
2005; Geser et al., 2012; Lonchel et al., 2012), this enzyme was
not identified during the period analyzed. A later penetration
of CTX-M-15 in Portugal (as occurred in other South European
countries) (Coque et al., 2008) might have resulted in a lower col-
onization pressure in these years, in opposite of CTX-M-14 that
was already spread in non-nosocomial niches (Machado et al.,
2009).
In agreement with previous studies from the same time period
(Kang et al., 2005; Skurnik et al., 2005), integrons were found in a
low percentage of isolates (9%). All class 1 integron types identi-
fied in this study have been extensively found in the hospital and
community settings, including Portuguese food-producing ani-
mals, with the exception of the integron type XXIV1 (containing
the gene cassette aadA13 conferring resistance to streptomycin
and spectinomycin) (Machado et al., 2005; Vinué et al., 2008;
Ben Sallem et al., 2012). The gene cassette aadA13 seems to be
widespread among Portuguese E. coli isolates from pig faeces since
1998 (Machado et al., 2008). Its identification in different species
of Enterobacteriaceae including firstly in Morganella morganii,
highlights the highly transmissibility of certain genetic elements
carrying antibiotic resistance in this area. Class 2 integrons con-
tents resembled that of Tn1825 and the widely disseminated Tn7
(Biskri and Mazel, 2003; Machado et al., 2005).
The occurrence of sul genes was similar to that reported in
other studies, with sul2 being more commonly found than sul1,
and sul3 being scarcely observed (Enne et al., 2001; Grape et al.,
2003; Infante et al., 2005; Hammerum et al., 2006; Trobos et al.,
2008; Bailey et al., 2010). These high rates of sul genes are iden-
tical to those detected among food-producing animals which
are highly exposed to sulfonamides, and hence an involvement
of the food chain cannot be discarded (Perreten and Boerlin,
2003; Pena et al., 2004; Antunes et al., 2005; Hammerum et al.,
2006). The observation of sul3 in one isolate harboring intI1
but lacking sul1 suggests a replacement of sul1 by sul3, as pre-
viously reported in similar structures of Salmonella and E. coli
isolates (Antunes et al., 2007; Curião et al., 2011). Although sul
genes were not observed in some sulfonamide resistant isolates,
we could not discard the presence of other resistance mecha-
nisms, as mutations at the chromosomal gene (folP) for dihy-
dropteroate synthase (DHPS) (Sköld, 2001) or acquisition of
unknown genes.
Prevalence data on intestinal carriage of relevant antibiotic
resistance genes and/or structures promoting gene expression
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in different time periods are important to identify sources and
hotspots of antibiotic resistance with relevance for the human
health. In summary, data from this retrospective study rein-
force the relevance of human commensal flora as reservoir
of clinically relevant antibiotic resistance genes (blaCTX-M-14
or blaTEM153; sul)/genetic platforms (integrons and IncK plas-
mids). These findings impose future extensive follow-up eval-
uations in order to understand the trends of the antibiotic
resistance genes epidemiology in the community and clinical set-
tings over the time, and eventually anticipate the detection of
microorganisms with the potential to cause pandemics in the
future.
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